🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

25 recruiting trials

for Psoriasis (PsO)

Effect of Semaglutide in Patients With Psoriasis and Obesity NCT06937060Phase 31 site📍 Hong Kong The University of Hong Kong · Tests: semaglutide Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis NCT06801821n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) NCT06029257n/a1 site📍 Graz Almirall, S.A. · Tests: Tildrakizumab Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis NCT07298265n/a1 site📍 Toronto Charite University, Berlin, Germany Molecular Inflammation Board at the Center for Personalized Medicine NCT07132333n/a1 site📍 Tübingen University Hospital Tuebingen · Tests: Biologic Agent Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis NCT06982352Phase 13 sites📍 Fargo📍 Dallas📍 Amman LAPIX Therapeutics Inc. · Tests: LPX-TI641, Placebo SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) NCT07021495n/a8 sites📍 Nijmegen📍 Maastricht📍 Amsterdam Leiden University Medical Center A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) NCT06888193Phase 114 sites📍 Santa Monica📍 South Miami📍 Boston UCB Biopharma SRL · Tests: Bimekizumab PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study NCT07615712n/a1 site📍 Waltham CorEvitas · Tests: Observational (Non-Interventional) Registry A Prospective, Interventional, Exploratory Study Evaluating the Efficacy of Small-Molecule Compound XJH05 Ointment in the Treatment of Plaque Psoriasis NCT07780929NA1 site📍 Xi'an Xijing Hospital · Tests: XJH05 ointment, Calcipotriol ointment Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis NCT07401992Phase 41 site📍 Monterrey Hospital Universitario Dr. Jose E. Gonzalez · Tests: Semaglutide (Rybelsus®), Placebo A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults NCT07233291Phase 21 site📍 Al Mansurah Ahmed Ibrahim · Tests: Oral roflumilast Impact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in Canada NCT07370766n/a7 sites📍 Burlington📍 Hamilton📍 Kanata Chronicle Academy A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis NCT06979453Phase 3132 sites📍 Birmingham📍 Birmingham📍 Phoenix Bristol-Myers Squibb · Tests: Deucravacitinib, Placebo The CorEvitas Psoriasis (PSO) Registry NCT02707341n/a1 site📍 Waltham CorEvitas A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) NCT06857942Phase 439 sites📍 Phoenix📍 Fountain Valley📍 Fremont Eli Lilly and Company · Tests: Tirzepatide Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease NCT07455578Phase 12 sites📍 Charlestown📍 Birtinya Seismic Therapeutic AU Pty Ltd · Tests: S-4321 Retinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With Psoriatic Arthritis: A Case-Control Study. NCT07858591n/a1 site📍 Bursa Bursa Yuksek Ihtisas Training and Research Hospital · Tests: OCTA-SCP, OCTA-DCP, OCTA-RPC, OCTA-FAZ Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study NCT07169019EARLY Phase 11 site📍 Alexandria Alexandria University · Tests: Probiotics and methotrexate, Methotrexate A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS) NCT06987292n/a2 sites📍 Nanjing📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: IL-17i The Effects of Audio-Based Therapy on Anxiety in Psoriasis NCT07390487NA1 site📍 San Francisco University of California, San Francisco · Tests: Music Therapy, Pink Noise PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study NCT07648602n/a1 site📍 Waltham CorEvitas · Tests: Observational (Non-Interventional) Registry Modifying PEST for Psoriatic Arthritis Screening NCT06382051NA30 sites📍 Calgary📍 Edmonton📍 Edmonton Novartis Pharmaceuticals · Tests: PEST Screening group A Study to Assess Deucravacitinib Safety in Pregnancy NCT07017699n/a1 site📍 La Jolla Bristol-Myers Squibb · Tests: Deucravacitinib, Other systemic treatments for PsO Global Healthcare Study on Psoriasis NCT07634016n/a1 site📍 Zurich Julia Tatjana Maul
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy